Casdin Capital’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.5M Buy
700,000
+315,000
+82% +$7.44M 1.1% 17
2025
Q4
$12.5M Buy
385,000
+155,000
+67% +$6.64M 0.78% 20
2025
Q3
$13M Hold
230,000
1.09% 16
2025
Q2
$11.5M Buy
230,000
+30,000
+15% +$1.36M 1.04% 16
2025
Q1
$5.91M Buy
+200,000
New +$7.43M 0.48% 28

Other funds holding HIMS

Casdin Capital's HIMS Position: Q1 2026 in Review

Casdin Capital increased its Hims & Hers Health (HIMS) stake by 82% in Q1 2026, buying an estimated $7.44M and bringing the position to 700,000 shares worth $14.5M. The position accounts for 1.1% of the portfolio, ranked #17.

Casdin Capital first reported a position in HIMS in Q1 2025 and has held it in 5 quarters since. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Casdin Capital held 700,000 shares of Hims & Hers Health worth $14.5M as of Q1 2026.
  • Casdin Capital bought 315,000 Hims & Hers Health shares in Q1 2026, an estimated $7.44M.
  • Hims & Hers Health made up 1.1% of Casdin Capital's portfolio in Q1 2026, its #17 holding.
  • Casdin Capital first reported a position in Hims & Hers Health in Q1 2025 and has held it in 5 quarters since.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Casdin Capital's 13F filing for Q1 2026, filed 15 May 2026.